Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amniotic fluid embolism.

Derek J Tuffnell1

  • 1Bradford Hospitals NHS Trust, Bradford, UK. derek.tuffnell@bradfordhospitals.nhs.uk

Current Opinion in Obstetrics & Gynecology
|March 14, 2003
PubMed
Summary

Amniotic fluid embolism is a significant cause of maternal death globally. Early diagnosis and prompt resuscitation are crucial for improving outcomes in this rare but serious condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.

The Cochrane database of systematic reviews·2016
Same author

Interventions for women in subsequent pregnancies following obstetric anal sphincter injury to reduce the risk of recurrent injury and associated harms.

The Cochrane database of systematic reviews·2014
Same author

Severe maternal sepsis in the UK, 2011-2012: a national case-control study.

PLoS medicine·2014
Same author

Associations of circulating calcium and 25-hydroxyvitamin D with glucose metabolism in pregnancy: a cross-sectional study in European and South Asian women.

The Journal of clinical endocrinology and metabolism·2014
Same author

Treatments for gestational diabetes.

The Cochrane database of systematic reviews·2009
Same author

Does treatment with 17 alpha-hydroxyprogesterone caproate increase the risk of gestational diabetes mellitus?

Nature clinical practice. Endocrinology & metabolism·2007

Area of Science:

  • Obstetrics and Gynecology
  • Critical Care Medicine
  • Maternal Health

Background:

  • Amniotic fluid embolism (AFE) remains a critical cause of maternal mortality worldwide.
  • International studies highlight AFE as a leading contributor to direct maternal deaths in the UK, France, and Singapore.
  • Despite its severity, recent data suggest case-specific mortality may be lower than previously estimated.

Purpose of the Study:

  • To review current literature on amniotic fluid embolism (AFE).
  • To analyze the influence of AFE on clinical management and future research.
  • To describe international morbidity and mortality associated with AFE.

Main Methods:

  • Literature review of recent studies on amniotic fluid embolism.
  • Analysis of data from Confidential Enquiries into Maternal Deaths (UK) and other international reports.
  • Examination of case reports and registry data for insights into diagnosis and treatment.

Main Results:

  • Mortality from AFE in the UK has decreased but remains a significant cause of maternal death.
  • AFE is the third leading cause of maternal death in France and the most common cause in Singapore.
  • UK Register data indicate a 16% mortality rate for AFE, with substantial maternal and neonatal morbidity; early diagnosis is key to improving outcomes.
  • Plasma exchange may be beneficial post-resuscitation.

Conclusions:

  • Early consideration of amniotic fluid embolism diagnosis is essential following prompt resuscitation.
  • Sparse literature exists for this rare condition, necessitating further research.
  • Advancing the understanding and management of AFE requires additional data collection and study.

Related Experiment Videos